Try our Advanced Search for more refined results
- Law360
- Law360 UK
- Law360 Pulse
- Law360 Employment Authority
- Law360 Tax Authority
- Law360 Insurance Authority
- Law360 Real Estate Authority
- Law360 Healthcare Authority
- Law360 Bankruptcy Authority
- Products
- Lexis®
- Law360 In-Depth
- Law360 Podcasts
- Rankings
- Regional Powerhouses
- Law360's MVPs
- Women in Law Report
- Law360 400
- Diversity Snapshot
- Practice Groups of the Year
- Rising Stars
- Titans of the Plaintiffs Bar
- Sections
- Adv. Search & Platform Tools
- About all sections
- Browse all sections
- Banking
- Bankruptcy
- Class Action
- Competition
- Employment
- Energy
- Expert Analysis
- Insurance
- Intellectual Property
- Product Liability
- Securities
- Beta Tools
- Track docs
- Track attorneys
- Track judges
SpecGx LLC v. Underwood et al
-
December 19, 2018
Judge Finds NY's $600M Opioid Surcharge Unconstitutional
New York's $600 million fee on the sale of opioids into the state unconstitutionally prohibits pharmaceutical companies from passing the cost onto consumers, a federal judge said Wednesday in halting payments to the state ahead of a Jan. 1 deadline.
-
December 10, 2018
Judge Mulls Several Outcomes For NY Opioid Surcharge Law
A Manhattan judge probed the pharmaceutical industry's attack on New York's $600 million levy on the opioid industry and the state's defense of the law at a Monday hearing, asking questions that suggested a range of outcomes were on the table between letting the law be and striking it down.
-
November 28, 2018
NY AG Asks Court To Toss Drugmaker's Opioid Surcharge Suit
The New York state attorney general's office has asked a federal court to dismiss a lawsuit against the state by a Mallinckrodt PLC subsidiary, one of three cases brought by the drug industry challenging New York's six-year, $600 million surcharge on pharmaceutical manufacturers and distributors of opioids.